Literature DB >> 3004618

Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma.

S D Smith, R Morgan, M P Link, P McFall, F Hecht.   

Abstract

Cell lines were established from five patients with T cell malignancies. Two patients had T cell lymphoblastic lymphoma (T-LL), whereas three patients had T cell acute lymphoblastic leukemia (T-ALL). Both T-LL cell lines expressed cell surface antigens characteristic of midthymocytes (Leu 2, 3, 6+). One T-ALL cell line also expressed this immunophenotype, one expressed suppressor/cytotoxic antigens (Leu 2+; Leu 3, 6-), and one expressed antigens of a mature but uncommitted T cell (Leu 4+; Leu 2, 3, 6-). Cytogenetic analysis showed that each cell line had 46 chromosomes with pseudodiploidy. The three T-ALL cell lines had only a few chromosome changes; one cell line had one deletion, another had two deletions, and the third had a translocation and two deletions (including loss of part of 9p). In comparison, both T-LL cell lines had complex chromosome changes, including most notably a rearrangement of band 14q11.2. The immunophenotypes and chromosome breakpoints showed patterns of interlock between the T-LL and T-ALL cell lines because common abnormalities occurred at six distinct chromosome sites. Cell lines with limited and specific chromosomal abnormalities are important because they can provide the basic material for molecular genetic studies that could elucidate the genetic mechanisms involved in neoplasia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004618

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms.

Authors:  A Bourguin; R Tung; N Galili; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 2.  Cytogenetics of malignant lymphomas.

Authors:  C Fonatsch
Journal:  Blut       Date:  1988-09

3.  Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease.

Authors:  H K Gershenfeld; R J Hershberger; T B Shows; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

5.  The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed.

Authors:  Y Laabi; M P Gras; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

6.  Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia.

Authors:  C A Westbrook; C M Rubin; M M Le Beau; L S Kaminer; S D Smith; J D Rowley; M O Diaz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 7.  Genetic and cytogenetic changes in acute lymphoblastic leukemia.

Authors:  H G Ahuja; M J Cline
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

8.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.

Authors:  M O Diaz; S Ziemin; M M Le Beau; P Pitha; S D Smith; R R Chilcote; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Growth of large chromosomally abnormal T cell clones in ataxia telangiectasia patients is associated with translocation at 14q11. A model for other T cell neoplasia.

Authors:  R J Hollis; A A Kennaugh; S V Butterworth; A M Taylor
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

10.  Molecular characterization of ataxia telangiectasia T cell clones. II. The clonal inv(14) in ataxia telangiectasia differs from the inv(14) in T cell lymphoma.

Authors:  F Zhang; M H Stern; G Thomas; A Aurias
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.